A new type of sarcoma identified
07.09.2015 - Press release
Inserm teams led by Prof. Jean-Yves Blay and Christophe Caux in Lyon , and by Franck Tirode and Olivier Delattre in Paris have just demonstrated a new genetic variant in tumours that had not been identified until now ...
A new virus in liver cancer
25.08.2015 - Press release
More than a cause of a simple infection, viruses are often involved in the development of serious diseases. Such is the case with liver cancer, which often develops in an organ that has been weakened by hepatitis B or C virus. Researchers ...
Production of iPS cells: discovery of the 5th element
08.07.2015 - Press release
Two teams of researchers from Inserm, CNRS, Centre Léon Bérard and Claude Bernard Lyon 1 University have discovered a molecule that may favour the production of these induced stem cells. ...
Restoring natural immunity against cancers
16.06.2015 - Press release
Scientists at the Institut Pasteur and Inserm have successfully increased the infiltration of immune cells into tumors, thus inducing the immune system to block tumor growth. ...
How a tumour mechanically transforms its healthy neighbouring cells into tumour cells and amplifies its own development
12.05.2015 - Press release
A growing tumour exerts considerable ongoing abnormal pressure on the healthy neighbouring cells. The CNRS/UPMC/Institut Curie team directed by Emmanuel Farge, Inserm Research Director at Institut Curie, has just discovered that this force can induce tumour gene expression. ...
Targeting a host receptor instead of the virus: a new experimental approach against hepatitis C virus.
24.03.2015 - Press release
(Français) Une collaboration internationale conduite par le Professeur Thomas Baumert met en évidence qu’un anticorps monoclonal spécifiquement dirigé contre la claudine-1, permet de prévenir et de traiter une infection chronique par ce virus dans un modèle animal. ...